AEON Biopharma, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| FISCHER JOST | — | Purchase | 60,000 | $0.49 | $29,400 | 266,785 | May 21, 2025 |
| FISCHER JOST | — | Purchase | 50,000 | $0.50 | $25,000 | 146,785 | May 20, 2025 |
| Bancroft Robert E. | President & CEO | Award / Grant | 177,103 | — | — | 177,103 | May 14, 2025 |
| PALMISANO ROBERT J | — | Award / Grant | 36,021 | — | — | 36,021 | Aug 31, 2024 |
| Forth Marc | CHIEF EXECTUIVE OFFICER | Award / Grant | 470,692 | — | — | 750,547 | Aug 31, 2024 |
| Wilson Alexander Blair | EXEC VP, CLO & CORP SECRETARY | Award / Grant | 180,110 | — | — | 261,538 | Aug 31, 2024 |
| FISCHER JOST | — | Award / Grant | 36,021 | — | — | 96,785 | Aug 31, 2024 |
| Oh Chad | CHIEF MEDICAL OFFICER | Award / Grant | 192,117 | — | — | 292,545 | Aug 31, 2024 |
| Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | Award / Grant | 18,010 | — | — | 18,010 | Aug 31, 2024 |
| Carter Eric G | — | Award / Grant | 36,021 | — | — | 36,021 | Aug 31, 2024 |
| Thunen Shelley B | — | Award / Grant | 36,021 | — | — | 36,021 | Aug 31, 2024 |
| PALMISANO ROBERT J | — | Award / Grant | 36,021 | — | — | 36,021 | Aug 31, 2024 |
| Strathspey Crown Holdings Group, LLC | — | Sale | 7,380,394 | $10.00 | $73,803,940 | 2,031,773 | Aug 11, 2023 |
| Grodnensky Oleg | — | C | 89,163 | — | — | 6,989,163 | Jul 21, 2023 |
| FISCHER JOST | — | Award / Grant | 2,353 | — | — | 2,353 | Jul 21, 2023 |